What is he best known for?
The fields of study he is best known for:
John J. Rossi spends much of his time researching RNA, RNA interference, Molecular biology, Small interfering RNA and Gene silencing.
The RNA study combines topics in areas such as Gene expression and Virology.
His RNA interference research integrates issues from Small hairpin RNA, Computational biology and Bioinformatics.
His work in Molecular biology addresses issues such as RNA silencing, which are connected to fields such as RNA-induced silencing complex and RNA-induced transcriptional silencing.
The various areas that John J. Rossi examines in his Small interfering RNA study include Aptamer and In vivo.
His research in Gene silencing tackles topics such as microRNA which are related to areas like Drosha and Regulation of gene expression.
His most cited work include:
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma (1549 citations)
- Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells (1065 citations)
- Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells (1065 citations)
What are the main themes of his work throughout his whole career to date?
RNA, Molecular biology, RNA interference, Small interfering RNA and Ribozyme are his primary areas of study.
He interconnects Gene expression, Computational biology, Aptamer and Virology in the investigation of issues within RNA.
The concepts of his Virology study are interwoven with issues in Viral vector and Genetic enhancement.
His Molecular biology research includes elements of Cell culture, Transfection, DNA, Messenger RNA and Transcription.
As a part of the same scientific family, John J. Rossi mostly works in the field of RNA interference, focusing on Cell biology and, on occasion, Argonaute.
His study looks at the relationship between Small interfering RNA and topics such as RNA silencing, which overlap with RNA-induced silencing complex, RNA-induced transcriptional silencing and DNA-directed RNA interference.
He most often published in these fields:
- RNA (32.77%)
- Molecular biology (27.87%)
- RNA interference (27.36%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (9.97%)
- Aptamer (11.49%)
- RNA (32.77%)
In recent papers he was focusing on the following fields of study:
John J. Rossi mainly focuses on Cancer research, Aptamer, RNA, Computational biology and Cell biology.
His biological study spans a wide range of topics, including Molecular biology, Gene silencing, Oligonucleotide and Gene expression.
His research brings together the fields of RNA interference and Gene silencing.
His work on RNAi-Based Therapeutics is typically connected to Food and drug administration as part of general RNA interference study, connecting several disciplines of science.
John J. Rossi has researched Computational biology in several fields, including Drug discovery and Biomarker discovery.
His studies deal with areas such as Dicer, Small interfering RNA, microRNA, RNA splicing and Messenger RNA as well as Cell biology.
Between 2015 and 2021, his most popular works were:
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma (1549 citations)
- Aptamers as targeted therapeutics: current potential and challenges (569 citations)
- The current state and future directions of RNAi-based therapeutics. (276 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Aptamer, Computational biology, Cancer research, Lymphoma and RNA.
His research on Computational biology also deals with topics like
- Cancer that intertwine with fields like Nucleic acid and Cytotoxicity,
- Drug discovery and related Drug delivery and Nucleotide Metabolism.
His Cancer research research incorporates elements of Liver function, T cell, Transcription factor, CEBPA and Regulation of gene expression.
John J. Rossi has included themes like Chimeric antigen receptor, Oncology and Multicenter trial in his Lymphoma study.
His work on RNAi-Based Therapeutics and RNA interference as part of his general RNA study is frequently connected to Food and drug administration, thereby bridging the divide between different branches of science.
RNA interference is a primary field of his research addressed under Gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
